SARS-CoV-2 infection, discovered and isolated in Wuhan City, Hubei Province, China,
causes acute atypical respiratory symptoms and has led to profound changes in our lives …

In December 2019, a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was discovered in Wuhan, China, the rapid spread of which culminated in a global …

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening
conditions triggered by multiple intra-and extra-pulmonary injury factors, characterized by …

Background Inhaled nitric oxide (iNO) is used as rescue therapy in patients with refractory
hypoxemia due to severe COVID-19 acute respiratory distress syndrome (ARDS) despite the …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has been looming globally for
three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing …

Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a common condition
with high mortality. ALI/ARDS is caused by multiple etiologies, and the main clinical …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly emerged
coronavirus, has sparked a global pandemic with its airborne transmission and ability to …

Acute respiratory distress syndrome (ARDS) is a rapidly progressive form of respiratory
failure that accounts for 10% of admissions to the ICU and is associated with approximately …

The acute respiratory distress syndrome (ARDS) is a life-threatening condition that causes
respiratory failure. Despite numerous clinical trials, there are no molecularly targeted …

The respiratory system exposed to microorganisms continuously, and the pathogenicity of
these microbes not only contingent on their virulence factors, but also the host's immunity. A …